Business Description
United Orthopedic Corp
NAICS : 334510
SIC : 3842
ISIN : TW0004129002
Description
United Orthopedic Corp manufactures, develops, and distributes medical equipment such as orthopedic implants and precision medical devices. Its product line includes hip replacement systems, knee replacement systems, as well as oncology and custom implants. Its solutions are used to perform total hip/knee replacements and revisions, plus clinical education, service, and support for surgeons and hospitals.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 1.72 | |||||
| Interest Coverage | 12.16 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.17 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.9 | |||||
| 3-Year EBITDA Growth Rate | 28.4 | |||||
| 3-Year EPS without NRI Growth Rate | 63.7 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.85 | |||||
| 9-Day RSI | 39.29 | |||||
| 14-Day RSI | 40.57 | |||||
| 6-1 Month Momentum % | 50.54 | |||||
| 12-1 Month Momentum % | 61.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.79 | |||||
| Quick Ratio | 0.9 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 608.48 | |||||
| Days Sales Outstanding | 87.36 | |||||
| Days Payable | 75.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.42 | |||||
| Dividend Payout Ratio | 0.55 | |||||
| 3-Year Dividend Growth Rate | 40.5 | |||||
| Forward Dividend Yield % | 2.42 | |||||
| 5-Year Yield-on-Cost % | 2.46 | |||||
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 2.58 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.26 | |||||
| Operating Margin % | 13.66 | |||||
| Net Margin % | 9.78 | |||||
| FCF Margin % | -3.15 | |||||
| ROE % | 12.24 | |||||
| ROA % | 6.43 | |||||
| ROIC % | 8.94 | |||||
| ROC (Joel Greenblatt) % | 17.07 | |||||
| ROCE % | 13.1 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.51 | |||||
| PE Ratio without NRI | 22.94 | |||||
| Shiller PE Ratio | 44.43 | |||||
| Price-to-Owner-Earnings | 127.88 | |||||
| PEG Ratio | 1.18 | |||||
| PS Ratio | 2.19 | |||||
| PB Ratio | 2.36 | |||||
| Price-to-Tangible-Book | 2.82 | |||||
| Price-to-Operating-Cash-Flow | 20.13 | |||||
| EV-to-EBIT | 18.48 | |||||
| EV-to-EBITDA | 10.76 | |||||
| EV-to-Revenue | 2.6 | |||||
| EV-to-FCF | -81.79 | |||||
| Price-to-Projected-FCF | 3.74 | |||||
| Price-to-DCF (Earnings Based) | 1.84 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.2 | |||||
| Price-to-Graham-Number | 1.7 | |||||
| Price-to-Net-Current-Asset-Value | 17.92 | |||||
| Earnings Yield (Greenblatt) % | 5.42 | |||||
| FCF Yield % | -1.36 | |||||
| Forward Rate of Return (Yacktman) % | 20.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
United Orthopedic Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 3,929.887 | ||
| EPS (TTM) (NT$) | 4.18 | ||
| Beta | 0.66 | ||
| Volatility % | 39.41 | ||
| 14-Day RSI | 40.57 | ||
| 14-Day ATR (NT$) | 2.557627 | ||
| 20-Day SMA (NT$) | 96.61 | ||
| 12-1 Month Momentum % | 61.68 | ||
| 52-Week Range (NT$) | 57.8 - 110 | ||
| Shares Outstanding (Mil) | 96.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
United Orthopedic Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
United Orthopedic Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
United Orthopedic Corp Frequently Asked Questions
What is United Orthopedic Corp(ROCO:4129)'s stock price today?
The current price of ROCO:4129 is NT$94.10. The 52 week high of ROCO:4129 is NT$110.00 and 52 week low is NT$57.80.
When is next earnings date of United Orthopedic Corp(ROCO:4129)?
The next earnings date of United Orthopedic Corp(ROCO:4129) is .
Does United Orthopedic Corp(ROCO:4129) pay dividends? If so, how much?
The Dividend Yield %  of United Orthopedic Corp(ROCO:4129) is 2.42% (As of Today), Highest Dividend Payout Ratio of United Orthopedic Corp(ROCO:4129) was 2.35. The lowest was 0.3. And the median was 0.78. The  Forward Dividend Yield % of United Orthopedic Corp(ROCO:4129) is 2.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers